GOLDMAN SACHS GROUP INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$282,595,987
-3.3%
2,774,357
-4.2%
0.06%
-3.4%
Q2 2023$292,383,058
-31.6%
2,897,464
-37.6%
0.06%
-35.2%
Q1 2023$427,374,913
+151.0%
4,645,379
+147.6%
0.09%
+139.5%
Q4 2022$170,236,342
-16.6%
1,876,503
-30.1%
0.04%
-19.1%
Q3 2022$204,122,000
-8.4%
2,685,463
+1.9%
0.05%
-6.0%
Q2 2022$222,764,000
-8.7%
2,635,332
-5.3%
0.05%
-2.0%
Q1 2022$244,085,000
+27.6%
2,781,596
+27.2%
0.05%
+34.2%
Q4 2021$191,331,000
+11.7%
2,187,402
+4.4%
0.04%
+5.6%
Q3 2021$171,335,000
-18.5%
2,095,066
-9.1%
0.04%
-23.4%
Q2 2021$210,180,000
-9.3%
2,303,586
-15.0%
0.05%
-19.0%
Q1 2021$231,733,000
+50.7%
2,710,955
+66.4%
0.06%
+45.0%
Q4 2020$153,821,000
-2.6%
1,628,948
-10.3%
0.04%
-11.1%
Q3 2020$158,007,000
+3.1%
1,817,007
+3.6%
0.04%
-2.2%
Q2 2020$153,193,000
+3.7%
1,753,984
-2.1%
0.05%
-11.5%
Q1 2020$147,716,000
-4.0%
1,791,575
+10.3%
0.05%
+33.3%
Q4 2019$153,821,000
+11.2%
1,624,487
+2.0%
0.04%
-2.5%
Q3 2019$138,342,000
-13.9%
1,591,967
-9.6%
0.04%
-13.0%
Q2 2019$160,720,000
+30.5%
1,760,151
+37.4%
0.05%
+24.3%
Q1 2019$123,159,000
+0.8%
1,281,035
-10.0%
0.04%
-5.1%
Q4 2018$122,161,000
+3.1%
1,423,614
+3.6%
0.04%
+30.0%
Q3 2018$118,440,000
+30.6%
1,374,656
+14.5%
0.03%
+20.0%
Q2 2018$90,697,000
+3.2%
1,200,653
+10.4%
0.02%
+13.6%
Q1 2018$87,921,000
+5.8%
1,087,472
+9.8%
0.02%
+10.0%
Q4 2017$83,138,000
-2.1%
990,214
+0.1%
0.02%0.0%
Q3 2017$84,945,000
+9.6%
989,466
+6.6%
0.02%0.0%
Q2 2017$77,504,000
-11.5%
928,525
-21.3%
0.02%
-13.0%
Q1 2017$87,586,000
-44.4%
1,179,293
-45.5%
0.02%
-48.9%
Q4 2016$157,547,000
+90.0%
2,162,920
+105.9%
0.04%
+80.0%
Q3 2016$82,929,000
+12.4%
1,050,255
+17.5%
0.02%
+8.7%
Q2 2016$73,768,000
+9.8%
894,058
-3.6%
0.02%
+4.5%
Q1 2016$67,185,000
-33.2%
927,468
-20.6%
0.02%
-29.0%
Q4 2015$100,524,000
-11.5%
1,168,339
-5.4%
0.03%
-20.5%
Q3 2015$113,539,000
+36.8%
1,235,198
+46.3%
0.04%
+50.0%
Q2 2015$83,019,000
+4.4%
844,215
+4.7%
0.03%0.0%
Q1 2015$79,534,000
-8.9%
806,555
-14.4%
0.03%
-3.7%
Q4 2014$87,266,000
+1.7%
941,791
+3.4%
0.03%0.0%
Q3 2014$85,774,000
-12.0%
911,224
-15.4%
0.03%
-12.9%
Q2 2014$97,458,000
-11.9%
1,076,528
-17.3%
0.03%
-13.9%
Q1 2014$110,678,000
+22.3%
1,301,789
+15.6%
0.04%
+24.1%
Q4 2013$90,520,000
+58.9%
1,126,151
+51.6%
0.03%
+38.1%
Q3 2013$56,970,000
+61.3%
742,679
+48.7%
0.02%
+61.5%
Q2 2013$35,310,000
-17.5%
499,373
-26.1%
0.01%
-27.8%
Q4 2012$42,782,000
+3.5%
675,852
+0.2%
0.02%
+12.5%
Q3 2012$41,324,000
-59.8%
674,575
-63.3%
0.02%
-64.4%
Q2 2012$102,887,000
-55.6%
1,840,560
-56.0%
0.04%
-58.3%
Q1 2012$231,620,0004,180,0950.11%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders